Back to results
US 5,962,025 AGranted
Method for treatment of systemic sclerosis and related fibrotic diseases
AssigneeThe University of Tennessee Research Corporation
InventorsLaura Carbone, Andrew H. Kang, Kevin McKown, Arnold E. Postlethwaite, Jerome M. Seyer
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method and pharmaceutical formulations for the treatment of systemic sclerosis in mammals, by oral administration of collagen, including type I collagen, or biologically active peptide fragments thereof.
Claims8
A method for treating systemic sclerosis in a patient in need of said treatment comprising administering orally or by inhalation a composition consisting essentially of a therapeutically effective amount of a collagen to said patient and inducing tolerance to the collagen.
Dependencies are inferred from the claim text.